SBRT 2016

Approved targeted drugs

Medical Oncology

Radio-Oncology

Cetuximab

Cetuximab Panatimumab Erlotinib Trastuzumab Lapatinib Bevacizumab Axatinib Sorafenib Sunitinib

Head & Neck

Colorectal

Breast

Pancreas

NSCLC

Glioblastoma

Kidney

GIST

Pazopanib Ipilimumab Vandetanib

Thyroid

Head & Neck

ESTRO SBRT COURSE 2016 - Matthias Guckenberger

17

/